These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29233975)

  • 21. [Early case of osteomyelosclerosis manifesting as radiological changes in the skeleton].
    Sadkiewicz S; Piotrowska E; Gorczyca-Wiśniewşka E
    Wiad Lek; 1982 Jul; 35(9):599-602. PubMed ID: 6889784
    [No Abstract]   [Full Text] [Related]  

  • 22. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.
    Barosi G
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):129-40. PubMed ID: 25189724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelofibrotic transformation in essential thrombocythemia.
    Thiele J; Kvasnicka HM
    Haematologica; 2009 Mar; 94(3):431-3; author reply 433. PubMed ID: 19181785
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of zinc protoporphyrin measurement in the differentiation between primary myelofibrosis and essential thrombocythaemia.
    Metzgeroth G; Kanders EM; Erben P; Hofmann WK; Hastka J
    Ann Hematol; 2011 Apr; 90(4):389-94. PubMed ID: 20922526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment.
    Thiele J; Orazi A; Kvasnicka HM; Franco V; Boveri E; Gianelli U; Gisslinger H; Passamonti F; Tefferi A; Barbui T
    Haematologica; 2012 Mar; 97(3):e5-6; discussion e7-8. PubMed ID: 22383744
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis.
    Geissler K; Jäger E; Gisslinger B; Thiele J; Schwarzinger I; Gisslinger H
    Am J Hematol; 2014 Dec; 89(12):1157-8. PubMed ID: 25112775
    [No Abstract]   [Full Text] [Related]  

  • 27. Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
    Luque Paz D; Cottin L; Lippert E; Robin JB; Bescond C; Genevieve F; Boyer F; Quintin-Roue I; Rousselet MC; Burroni B; Hunault-Berger M; Ugo V; Ianotto JC; Orvain C
    Ann Hematol; 2022 Apr; 101(4):893-896. PubMed ID: 34611719
    [No Abstract]   [Full Text] [Related]  

  • 28. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of adults presenting with a thrombocytosis].
    Viallard JF
    Rev Med Interne; 2010 Dec; 31 Suppl 3():S333-8. PubMed ID: 21035235
    [No Abstract]   [Full Text] [Related]  

  • 30. Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia.
    Barbui T; Thiele J; Vannucchi AM; Tefferi A
    Leukemia; 2013 Oct; 27(10):1953-8. PubMed ID: 23467025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
    Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
    Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor-erythroid 2, nerve growth factor receptor, and CD34-microvessel density are differentially expressed in primary myelofibrosis, polycythemia vera, and essential thrombocythemia.
    Yigit N; Covey S; Barouk-Fox S; Turker T; Geyer JT; Orazi A
    Hum Pathol; 2015 Aug; 46(8):1217-25. PubMed ID: 26093937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.
    Carobbio A; Finazzi G; Thiele J; Kvasnicka HM; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Luigia Randi M; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Gangat N; Rambaldi A; Tefferi A; Barbui T
    Am J Hematol; 2012 Feb; 87(2):203-4. PubMed ID: 22237692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When nucleated RBCs "count" in the peripheral blood: a unique case of post-essential thrombocythemia myelofibrosis.
    Thompson M; Lynch D
    Blood; 2019 Apr; 133(15):1696. PubMed ID: 30975644
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach.
    Carobbio A; Vannucchi AM; Rumi E; De Stefano V; Rambaldi A; Carli G; Randi ML; Gisslinger H; Passamonti F; Thiele J; Gangat N; Tefferi A; Barbui T
    Blood Cancer J; 2023 Jul; 13(1):115. PubMed ID: 37507408
    [No Abstract]   [Full Text] [Related]  

  • 36. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
    Barbui T; Thiele J; Vannucchi AM; Tefferi A
    Blood Cancer J; 2015 Aug; 5(8):e337. PubMed ID: 26832847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J; Kvasnicka HM
    Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
    Passamonti F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S25-7. PubMed ID: 22035744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features--a clinicopathological study on 272 patients.
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2003 Jan; 18(1):93-102. PubMed ID: 12507288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
    Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
    J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.